Concepedia
Statistics
Publications
8
Citations
470
H-Index
Active since
2008
Affiliations
University of Colorado Denver(Current)
Tampa General Hospital
University of Michigan
St. Joseph's Hospital and Medical Center
The University of Texas Southwestern Medical Center
Tarik Haddad is an author at University of Colorado Denver specializing in medicine, pharmacotherapy, and infectious diseases.
Publications per year
2008–2023
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Ganesh Raghu, Fernando J. Martínez, Kevin K. Brown et al. · European Respiratory Journal · 2015 · 149 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis
Joseph M. Parker, Ian Glaspole, Lisa Lancaster et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 132 citations
Medicine, Immunology, Pharmacology +15
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
Jennifer L. Taylor‐Cousar, Manu Jain, Tara Lynn Barto et al. · Journal of Cystic Fibrosis · 2017 · 69 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant
Jens Gottlieb, Fernando Torres, Tarik Haddad et al. · The Journal of Heart and Lung Transplantation · 2023 · 38 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis
Nancy E. Rolfe, Tarik Haddad, Todd S. Wills · Medical Mycology Case Reports · 2013 · 24 citations · Full text
Medicine, Infectious Diseases, Microbiology +17
1–5 of 8